CA-INSPUR-INFORMATION
Inspur Information, a leading IT infrastructure provider, launched the new A6 server line that supports 3rd Gen AMD® EPYCTM Milan/Milan-X 7003 series processors. The A6 server line features multi-core capabilities that show outstanding performance leaps compared to previous generation of servers with an up to 28% performance increase in SPEC performance test. The A6 server line will serve as the foundation for compute-intensive applications in the enterprise scenarios, such as big data, multi-cloud and other high-demand computing applications.
“By launching the brand new A6 servers, Inspur aims to deliver better compute performance for reliable and efficient business support. The Inspur A6 server series features best-in-class performance, energy efficiency and scalability to address the enormous computing challenges imposed by the era of big data and digital transformation”, said Ricky Zhao, Deputy General Manager of Server Product Line and General Manager of Datacenter Product Line, Inspur Information.
“AMD has been collaborating with Inspur to deliver innovative and high-performance products to the market”, said Roger Benson, Senior Director of AMD. “The new A6 server line powered by AMD EPYCTM Milan/Milan-X 7003 series processors represents the latest achievement by AMD and Inspur. With multi-core configurations and a series of performance optimizations, this server solution will unleash more possibilities for handling complex and compute-intensive workloads.”
A6 servers showcase outstanding performance with multiple cores with a high-base frequency, providing industry-leading single core capabilities. Storage density and IOPS (input/output operations per second) are increased by more than threefold. With the precision engineering and multi-level security mechanisms, A6 servers are more intelligent, easy-to-use and safer. They ensure efficient and care-free operation. It is designed with open computing standards, such as the ORS6000E rack.
A6 servers are designed to provide ultimate performance
NF3180A6/ NF3280A6 is a 1U/2U 1S rack server based on 3rd Gen AMD® EPYCTM Milan processors. Powered by multiple cores with a high-base frequency, it can serve as a high-density and cost-effective rack server that delivers strong computing power comparable to traditional dual-socket servers. With the addition of flexible expansion, it can fulfill the specific requirements for cloud computing, distributed storage, big data, CDN, video transcoding, in-memory database and virtualization scenarios.
Inspur NF5180A6/NF5280A6, powered by 3rd Gen AMD® EPYCTM processors, is a high-density dual-socket server that offers strong computing performance, ecological compatibility and configuration flexibility. This server features high quality and strong reliability, which makes it the ideal choice for a variety of complicated workloads, especially data processing, virtualization, high performance and cloud computing.
Inspur i24A6 is a 2U4N multi-node server adopting AMD EPYC™ 7002/7003 processors. It has 24 storage drives, multiple network options, and 8x 3200 MHz RDIMM/LRDIMM. It is tailored for high-performance computing and hyper-scale, and other tasks that require high core counts, large storage capacity and flexible I/O solutions.
Inheriting the design DNA of Inspur Information’s renowned server products, the A6 server line represents industry-leading performance, design and security. The line will serve as an engine to promote industrial AI and digital transformation by offering a foundation for a variety of key scenarios including multi-cloud, high-performance computing and edge computing.
About Inspur Information
Inspur Information is a leading provider of data center infrastructure, cloud computing, and AI solutions. It is the world’s 2nd largest server manufacturer. Through engineering and innovation, Inspur Information delivers cutting-edge computing hardware design and extensive product offerings to address important technology sectors such as open computing, cloud data center, AI, and deep learning. Performance-optimized and purpose-built, our world-class solutions empower customers to tackle specific workloads and real-world challenges. To learn more, visit https://www.inspursystems.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220323005391/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom